25/02/2021 - 09:00 Portfolio Kind Technologies starts joint venture named HORTILOGICS B.V. Weiterlesen
15/02/2021 - 13:30 Corporate news 100x100 - CEO Koen Dejonckheere in conversation with Wassim Essebane Weiterlesen
29/01/2021 - 07:30 Finanziell Gimv announces share buyback in the context of a share purchase plan for its personnel Weiterlesen
21/01/2021 - 10:00 Portfolio Biotalys submits first protein-based biocontrol registration package to the EPA Weiterlesen
19/01/2021 - 14:30 Portfolio Gimv sells OTN Systems, a provider of telecommunication solutions for industrial markets, to listed Belden Inc. Weiterlesen
10/12/2020 - 11:00 Portfolio Cegeka and Citymesh join forces to form a fourth national operator in Belgium Weiterlesen
02/12/2020 - 07:30 Portfolio Gimv sells Itho Daalderop-Climate for Life - Dutch market leader in integrated sustainable solutions for energy-neutral living in the Benelux - to Parcom Weiterlesen
30/11/2020 - 08:00 Portfolio Gimv is founding investor of Kinaset Therapeutics in a USD 40m Series A round – funds used to develop novel therapeutics for respiratory diseases Weiterlesen
25/11/2020 - 09:00 Portfolio Kind Technologies acquires Martin Stolze for further growth within the horticulture greenhouse market Weiterlesen
19/11/2020 - 07:30 Portfolio Gimv invests in SynOx Therapeutics which raises EUR 37 million to develop emactuzumab for treatment of tenosynovial giant cell tumors Weiterlesen
19/11/2020 - 07:00 Finanziell Beteiligungsgesellschaft Gimv: Starke Ergebnisse dank eines widerstandsfähigen Portfolios Weiterlesen
11/11/2020 - 13:00 Portfolio ImCheck Presents at SITC First Clinical Demonstration of Gamma Delta T Cell Activation and Tumor Infiltration with Positive Safety for ICT01 Weiterlesen
06/11/2020 - 08:10 Portfolio Die Firmengruppe Köberl beginnt Wachstumsinitiative mit dem Erwerb der 089 Immobilienmanagement GmbH Weiterlesen
22/10/2020 - 17:55 Portfolio Gimv and founder sell Eurocept Homecare - active in ’Hospital-at-home‘ services and complex wound care - to Mediq Weiterlesen
19/10/2020 - 09:18 Portfolio Topas Therapeutics raises EUR 22 Million in Series B Financing and appoints new CEO Weiterlesen
01/10/2020 - 07:30 Portfolio Gimv invests in French company Biolam for further roll-out as regional challenger in medical diagnostics laboratories Weiterlesen
30/09/2020 - 12:07 Portfolio 2020 09 29 - Repositionnement plus écologique pour le groupe AgroBiothers Weiterlesen
30/09/2020 - 11:48 Corporate news Gimv is 40: Wij doen wat veel fondsen niet durven' Uit Trends van 24/09/2020 Weiterlesen
15/09/2020 - 11:19 Portfolio ImCheck Announces Investment by BB Pureos Bioventures to Close Series B Fundraising with Total of €54 million ($64 million) Weiterlesen
20/08/2020 - 10:55 Portfolio Melijoe and Gimv join forces with The Babyshop Group to strengthen global leadership in high-end children's fashion Weiterlesen
23/07/2020 - 17:45 Finanziell Outcome of the optional dividend for the financial year 2019/2020: 63.4% of the dividend rights on the financial year 2019/2020 are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 28.2 million. Weiterlesen
02/07/2020 - 14:04 Portfolio Grandeco shifts up a gear thanks to the strategic acquisition of Holden Decor Limited, one of UK's leading wallcovering companies Weiterlesen
29/06/2020 - 17:50 Portfolio Gimv, D2E and founders sell logistics service provider Contraload to Tosca, an American player in reusable packaging and supply chain solutions Weiterlesen
